Lantheus
LNTH
Hutchmed (China)
HCM
Workday
WDAY
DexCom
DXCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -1,117.50%-1.01M | -498.13%-497.64K | -88.36K | -52.88K | -374.08K | -83.2K | -83.2K | 0 | 0 | 0 |
Net income from continuing operations | 545.55%1.38M | -562.00%-45.06K | 439.47%465.53K | 898.95%481.93K | 552.89%473.42K | -70.60%-308.79K | 92.33%-6.81K | ---137.13K | ---60.32K | ---104.53K |
Other non cash items | -1,471.27%-3.54M | -1,147.97%-820.42K | -2,048.01%-915.96K | -2,595.72%-931.43K | -1,012.04%-869.39K | 127.07%257.95K | 263.12%78.29K | --47.02K | --37.32K | --95.32K |
Change In working capital | 3,649.07%1.15M | 340.98%372.74K | 333.01%390.2K | 1,480.81%363.57K | 137.77%21.9K | -148.01%-32.36K | -330.07%-154.68K | --90.11K | --23K | --9.21K |
-Change in receivables | ---- | ---- | ---- | --200K | ---206.5K | ---- | ---- | ---- | --0 | --0 |
-Change in prepaid assets | 70.12%-9.91K | 175.86%25.15K | --73.29K | --16.82K | ---125.17K | ---33.16K | ---33.16K | --0 | --0 | --0 |
-Change in payables and accrued expense | 144,870.59%1.16M | 386.03%347.59K | 244.46%310.41K | 538.07%146.75K | 3,739.37%353.57K | -98.81%799 | -280.75%-121.52K | --90.11K | --23K | --9.21K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -1,117.50%-1.01M | -498.13%-497.64K | ---88.36K | ---52.88K | ---374.08K | ---83.2K | ---83.2K | --0 | --0 | --0 |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 99.67%-226.43K | 99.67%-229.77K | 0 | 1 | 3.34K | -69M | -69M | 0 | ||
Net other investing changes | 99.67%-226.43K | ---229.77K | --0 | --1 | --3.34K | ---69M | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 99.67%-226.43K | 99.67%-229.77K | --0 | --1 | --3.34K | ---69M | ---69M | --0 | --0 | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -99.16%582.87K | -98.96%724.78K | 0 | -35K | -106.91K | 69.74M | 69.74M | 0 | 0 | 0 |
Net issuance payments of debt | 171.44%724.78K | ---- | ---- | ---- | ---- | ---1.01M | ---- | ---- | ---- | ---- |
Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --68.41M | ---- | ---- | ---- | ---- |
Proceeds from stock option exercised by employees | --0 | ---- | ---- | ---- | ---- | --2.46M | ---- | ---- | ---- | ---- |
Net other financing activities | -22.55%-141.91K | --0 | --0 | ---35K | ---106.91K | ---115.8K | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -99.16%582.87K | -98.96%724.78K | --0 | ---35K | ---106.91K | --69.74M | --69.74M | --0 | --0 | --0 |
Net cash flow | ||||||||||
Beginning cash position | --656.98K | --3.08K | --91.45K | --179.32K | --656.98K | --0 | --0 | --0 | --0 | --0 |
Current changes in cash | -199.93%-656.52K | ---2.63K | ---88.36K | ---87.88K | ---477.65K | --656.98K | ---- | ---- | ---- | ---- |
End cash Position | -99.93%454 | -99.93%454 | --3.08K | --91.45K | --179.32K | --656.98K | --656.98K | --0 | --0 | --0 |
Free cash flow | -1,117.50%-1.01M | -498.13%-497.64K | ---88.36K | ---52.88K | ---374.08K | ---83.2K | ---83.2K | --0 | --0 | --0 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |